[1] |
Yun-fang MA, Li-na PAN, Zhen LI, Bei-li GAO, Jia-an HU, Zhi-hong XU.
Exploratory study on downregulation of PD-L1 in KRAS G12V-mutant non-small cell lung cancer cells by selumetinib
[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(6): 741-748.
|
[2] |
Jian-hua XU, Ping JIANG, Jiong DENG.
Expression and significance of ATP-binding cassette superfamily G member 2 in lung cancer
[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(6): 830-833.
|
[3] |
XU Shu-lin, WU Jing, LOU Jia-tao.
Correlation analysis of lung cancer and anemia
[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(11): 1500-1504.
|
[4] |
HE Chun-ming, YIN Hang, TANG Jian, DING Yi-zong, FU Yu-jie, ZHAO Xiao-jing.
Establishment and internal validation of a prognostic model for elderly patients after lung cancer surgery based on SEER
[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(11): 1554-1561.
|
[5] |
ZHOU Zhen, XU Yun-hua, ZHANG Fei-fei, ZHAO Yi, GUO Lin, FU Guo-long, SHEN Sheng-ping, LENG Xue-jiao.
Establishment of a lung cancer momodel with humanized immunity and its role in efficacy evaluation of programmed death-1 inhibitors
[J]. , 2020, 40(1): 37-.
|
[6] |
ZOU Chen1, 2, XU Run-hao1, 3, ZHANG Hong2, MA Zhan2, CHEN Li2, ZHANG Jie3, LI Min3, ZHANG Shu-lin1.
Potential roles of small metabolites in the differential diagnosis between lung cancer and pneumonia
[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(08): 1041-1047.
|
[7] |
HE Chun-ming, YIN Hang, ZHENG Jia-jie, TANG Jian, FU Yu-jie, ZHAO Xiao-jing.
Immunotherapy for lung cancer: immunosuppressive cells and intrapulmonary immunity
[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(08): 1137-1142.
|
[8] |
HU Meng-wei1, LI Miao-miao1, HUANG Wan-ying1, WANG Yu1, HU Yong-bo1, ZHANG Rui1, HOU Li-na1, CHEN Hong-zhuan1, ZHANG Yong-fang1, WANG Ling2, TAN Wen2, XU Jian-rong1, WANG Hao1.
Pharmacokinetic studies of DDDA3, a promising dual inhibitor of cholinesterases in rat plasmaHPLC-MS/MS
[J]. , 2019, 39(11): 1233-.
|
[9] |
QU Guo-jun1, LU Yuan-feng2, LI Yu1.
Mechanism of CCT2, a new downstream substrate of PDGFRα, on proliferation of tumor cells
[J]. , 2019, 39(1): 28-.
|
[10] |
LI Hui*, ZHANG Shu-tao*, YUE Bing.
Small peptide KR-12-a5 promotes the osteogenic differentiation of human bone marrow mesenchymal stem cells
[J]. , 2018, 38(8): 881-.
|
[11] |
HE Ya-ping1, LOU Wei-qun2, CHEN Jie-ling2, ZHOU Zhen3, ZHU Jing-fen1, JIAN Hong3.
Influencing factors for quality of life in patients over 12 months after diagnosis of non-small cell lung cancer
[J]. , 2018, 38(7): 775-.
|
[12] |
DAI Wei, WANG Xiao-wen, HUANG Chun, XIANG Xiao-yong, JIANG Yin-jiu, WU Qing-chen.
Research progress in the risk factors and mechanisms of postoperative atrial fibrillation after lung cancer surgery
[J]. , 2018, 38(5): 573-.
|
[13] |
ZHANG Li-yan, TAN Xiao-ming.
Application in diagnosis and treatment of circulating tumor cell detection in lung cancer#br#
[J]. , 2018, 38(3): 343-.
|
[14] |
YU Huan1,LI Qing-yun2.
Research progress of the local treatments on choroidal metastasis of lung cancer
[J]. , 2018, 38(2): 233-.
|
[15] |
WANG Ye, XIE Wang, ZHANG Jie, SHENG Jie-ying, GUO Zhong-liang.
Mechanism of hsa-miRNA124-3p regulating the proliferation and migration of human lung cancer cell line NCI-H460#br#
[J]. , 2017, 37(8): 1051-.
|